Editorial: Advances in understanding and managing systemic sclerosis-associated interstitial lung disease: bridging prognostic biomarkers to therapeutic innovations
Front Med (Lausanne). 2025 Sep 16;12:1683554. doi: 10.3389/fmed.2025.1683554. eCollection 2025. NO ABSTRACT PMID:41035864 | PMC:PMC12479534 | DOI:10.3389/fmed.2025.1683554

